RHEONIX, INC.
ITHACA, NY · Founded 2008 · CIK 0001454559 · Medtech · Defunct
Microfluidic point-of-care device for simultaneous HIV antibody and viral RNA detection using lateral flow and isothermal amplification (LAMP)
- Grants
- $2.2M
- 3 awards
- Sector median: 1
- Raised
- $45M
- 5 Form D · Jun 2020
- 76 months since last filing
- Contracts
- $73K
- 1 award · Health and Human S
- #548 of 4531 in medtech
- Patents
- 33
- 20 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $11,524,758 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-care Detection of HIV Antibodies and RNA in Blood and Saliva | $998,469 | |
| Private capital raised | Form D · SEC | $21,862,496 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-care Detection of HIV Antibodies and RNA in Blood and Saliva | $496,122 | |
| Federal grant | Department of Health and Human Services · Phase II · Point-of-care Detection of HIV Antibodies and RNA in Blood and Saliva | $656,414 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Liquid Handler | $72,500 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 545 | GENERAL OPTICS LLC | $75K | — |
| 546 | DesiCorp, Inc. | $75K | $1.8M |
| 547 | LUMO IMAGING LLC | $74K | — |
| 548 | RHEONIX, INC. | $73K | $45M |
| 549 | BIODESIX INC | $70K | $156M |
| 550 | LASMED LTD LIABILITY CORP | $70K | — |
| 551 | Focus Ventures, Inc. | $69K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John BrennerExecutive Officer
- Anthony EisenhutExecutive Officer
- Gregory GalvinDirector · Executive Officer
- Christopher SmithExecutive Officer
Patents
- Microfluidic Apparatus, Method, And Applicationsgranted
- Channel-less Pump, Methods, And Applications Thereofapplication
- Channel-less Pump, Methods, And Applications Thereofgranted
- Microfluidic Apparatus, Method, And Applicationsgranted
- Quantitative Multiplexed Identification Of Nucleic Acid Targetsgranted
- Channel-less Pump, Methods, And Applications Thereofgranted
- Strain Typing Assay and Method Without Need for Isolation in Pure Form and Subsequent Longitudinal Strain Trackingapplication
- Microfluidic Pump And Valve Structures And Fabrication Methodsgranted
- Microfluidic Apparatus, Method, And Applicationsgranted
- Microfluidic Pump And Valve Structures And Fabrication Methodsgranted
- Self-contained Biological Assay Apparatus, Methods, and Applicationsgranted
- Self-contained Biological Assay Apparatus, Methods, And Applicationsgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.